
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 930 | 930 | 861 | 1051 | 1229 | 1541 |
Fund Return | -7.02% | -7.02% | -13.94% | 1.67% | 4.21% | 4.42% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FCP MEDICAL BioHealth-Trends EUR | 497.92M | -9.66 | 5.16 | 6.48 | ||
FCP MEDICAL BioHealth Trends I | 497.92M | -9.55 | 5.69 | 7.35 | ||
FCP MEDICAL BioHealth Trends I H | 497.92M | -6.95 | 1.88 | 5.17 | ||
FFPB MultiTrend Plus | 216.06M | 1.82 | 2.95 | 1.83 | ||
FFPB Dividenden Select | 64.72M | 10.95 | 5.25 | 3.75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A EUR H AccE | 59.11B | -2.42 | 9.05 | 6.45 | ||
Invesco JapEqAdvantage C EUR H AccE | 59.11B | -2.18 | 10.05 | 7.30 | ||
LU1482751903 | 394.41M | -5.40 | 9.27 | - | ||
LU1841614867 | 239.11M | -5.55 | 8.31 | - | ||
Morgan Stanley Global Brands AH | 19.46B | 0.93 | 1.53 | 7.02 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Insmed | US4576693075 | 6.41 | 68.57 | +5.80% | |
Crinetics Pharma | US22663K1079 | 5.69 | 29.11 | +8.42% | |
UCB | BE0003739530 | 5.15 | 133.50 | -0.85% | |
argenx ADR | US04016X1019 | 4.60 | 580.94 | +6.36% | |
Tarsus | US87650L1035 | 3.93 | 46.43 | +5.24% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review